David Zaccardelli - 01 May 2022 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
President and CEO, Director
Signature
/s/ Claire Poll, Attorney-in-fact for David Zaccardelli
Issuer symbol
VRNA
Transactions as of
01 May 2022
Net transactions value
-$237,666
Form type
4
Filing time
03 May 2022, 20:17:15 UTC
Previous filing
03 Feb 2022
Next filing
05 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Tax liability $237,666 -454,864 -2.7% $0.5225* 16,384,232 01 May 2022 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
F3 The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on April 29, 2022 divided by eight (8).
F4 Consists of (i) 8,342,256 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 1,042,782 ADSs); and (ii) 8,041,976 Ordinary Shares underlying 1,005,247 ADSs.